These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32962917)

  • 1. Immunohematologic aspects of alloimmunization and alloantibody detection: A focus on pregnancy and hemolytic disease of the fetus and newborn.
    Gupta GK; Balbuena-Merle R; Hendrickson JE; Tormey CA
    Transfus Apher Sci; 2020 Oct; 59(5):102946. PubMed ID: 32962917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
    Hendrickson JE; Delaney M
    Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red Blood Cell Alloimmunization in the Pregnant Patient.
    Webb J; Delaney M
    Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
    Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
    Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model.
    Stowell SR; Henry KL; Smith NH; Hudson KE; Halverson GR; Park JC; Bennett AM; Girard-Pierce KR; Arthur CM; Bunting ST; Zimring JC; Hendrickson JE
    Blood; 2013 Aug; 122(8):1494-504. PubMed ID: 23801629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell alloimmunization: new findings at the bench and new recommendations for the bedside.
    Hendrickson JE; Eisenbarth SC; Tormey CA
    Curr Opin Hematol; 2016 Nov; 23(6):543-549. PubMed ID: 27454234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cell alloimmunization from an African perspective.
    Natukunda B; Brand A; Schonewille H
    Curr Opin Hematol; 2010 Nov; 17(6):565-70. PubMed ID: 20827185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Insights Into K-associated Fetal Anemia and Potential Treatment Strategies for Sensitized Pregnancies.
    Carpenter MC; Souter SC; Zipkin RJ; Ackerman ME
    Transfus Med Rev; 2024 Jan; 38(1):150779. PubMed ID: 37926651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
    Roubalová L; Lubušký M
    Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn.
    Moise KJ; Morales Y; Bertholf MF; Rossmann SN; Bai Y
    Immunohematology; 2017 Dec; 33(4):151-154. PubMed ID: 29378146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red Blood Cell Antibodies in Hematology/Oncology Patients: Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies.
    Hendrickson JE; Tormey CA
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):635-51. PubMed ID: 27113001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroblastosis fetalis produced by anti-k.
    Bowman JM; Harman FA; Manning CR; Pollock JM
    Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding red blood cell alloimmunization triggers.
    Hendrickson JE; Tormey CA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):446-451. PubMed ID: 27913514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands.
    Luken JS; Folman CC; Lukens MV; Meekers JH; Ligthart PC; Schonewille H; Zwaginga JJ; Janssen MP; van der Schoot CE; van der Bom JG; de Haas M
    Transfusion; 2021 Mar; 61(3):713-721. PubMed ID: 33528025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-E alloimmunization in pregnancy: management dilemmas.
    To WW; Ho SN; Mok KM
    J Obstet Gynaecol Res; 2003 Feb; 29(1):45-8. PubMed ID: 12696627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.